Provided by Tiger Trade Technology Pte. Ltd.

enVVeno Medical Corp.

11.85
+1.8618.62%
Post-market: 11.850.00000.00%19:49 EST
Volume:41.65K
Turnover:477.17K
Market Cap:7.75M
PE:-0.31
High:12.32
Open:10.27
Low:10.27
Close:9.99
52wk High:196.70
52wk Low:8.67
Shares:654.30K
Float Shares:503.00K
Volume Ratio:4.49
T/O Rate:8.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-37.8534
EPS(LYR):-44.5493
ROE:-57.19%
ROA:-35.12%
PB:0.26
PE(LYR):-0.27

Loading ...

Braeden Lichti- Reports 5.05% Stake in enVVeno Medical Corp as of Feb 20 - SEC Filing

THOMSON REUTERS
·
Feb 20

Braeden Lichti- Northstrive's Fund Recommendations to Envvenos Board to Launch Formal Strategic Review to Either Return Capital or Pursue Merger

THOMSON REUTERS
·
Feb 20

Braeden Lichti- Northstrive's Fund Recommendations to enVVeno Medical's Board to Immediately Halt All Clinical Operations

THOMSON REUTERS
·
Feb 20

NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM

Reuters
·
Jan 18

enVVeno Medical trading halted, news pending

TIPRANKS
·
Jan 17

enVVeno Medical Executes 1-for-35 Reverse Stock Split

Reuters
·
Jan 15

Director Francis Duhay Reports Disposal of enVVeno Medical Corp. Common Shares

Reuters
·
Dec 13, 2025

enVVeno Medical Corp. Held Annual Stockholder Meeting

Reuters
·
Dec 13, 2025

enVVeno Medical CEO to Join Live Virtual Investor CEO Connect Segment

Reuters
·
Nov 26, 2025

enVVeno Medical Lowers Stockholder Quorum Requirement

Reuters
·
Nov 21, 2025

EnVVeno Medical Loses Appeal of FDA Not-Approvable Letter for VenoValve

Dow Jones
·
Nov 14, 2025

enVVeno Medical trading halted, news pending

TIPRANKS
·
Nov 14, 2025

enVVeno Medical Corp - May Sell up to $50 Mln of Shares - SEC Filing

THOMSON REUTERS
·
Oct 31, 2025

enVVeno Medical Corp. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Oct 31, 2025

enVVeno Medical Corp expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
Oct 27, 2025

enVVeno Medical Corp receives Nasdaq notice for failing to meet minimum bid price requirement

Reuters
·
Oct 10, 2025

enVVeno Medical Corp. Files Supervisory Appeal After FDA Issues Not-Approvable Letter for VenoValve® PMA; Ongoing Regulatory Review Continues

Reuters
·
Sep 26, 2025

enVVeno Medical to file request for appeal of CDRH non-approvable letter

TIPRANKS
·
Sep 15, 2025

enVVeno Medical Corp. Files Supervisory Appeal with FDA for VenoValve® Approval Following Not-Approvable Letter

Reuters
·
Sep 15, 2025